New poll shows about half of U.S. adults believe it is a good thing for adults to use weight-loss drugs if they are ...
Because the drug doesn’t target the brain, it has less potential for addiction. Learn why this could help the opioid crisis.
Fact checked by Nick Blackmer The Food and Drug Administration (FDA) on Thursday approved Journavx (suzetrigine), a new non-opioid painkiller that promises to be nonaddictive. Journavx is approved to ...
The Food and Drug Administration has approved a first-of-its-kind non-opioid pain medication, providing a new option for ...